// App-Quantinova.ai

PO‐094 : Apixaban for thromboprophylaxis in myeloma treated with immunomodulatory therapy appears to be safe and effective

Researchers

Presenter

  • N Storrar

Principal Investigators

  • A Mathur

  • H Roddie

Medical Centers

  • Department of Haematology, Western General Hospital

  • Medical Genetics Section, University of Edinburgh, Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved